56 related articles for article (PubMed ID: 18645097)
21. Noncosmetic periocular therapeutic applications of botulinum toxin.
Kaynak-Hekimhan P
Middle East Afr J Ophthalmol; 2010 Apr; 17(2):113-20. PubMed ID: 20616916
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of fresh versus refrigerated botulinum toxin in the treatment of lateral periorbital rhytids.
Hui JI; Lee WW
Ophthalmic Plast Reconstr Surg; 2007; 23(6):433-8. PubMed ID: 18030112
[TBL] [Abstract][Full Text] [Related]
23. Addition of an anesthetic agent to enhance the predictability of the effects of botulinum toxin type A injections: a randomized controlled study.
Gassner HG; Sherris DA
Mayo Clin Proc; 2000 Jul; 75(7):701-4. PubMed ID: 10907385
[TBL] [Abstract][Full Text] [Related]
24. Pain difference associated with injection of abobotulinumtoxinA reconstituted with preserved saline and preservative-free saline: a prospective, randomized, side-by-side, double-blind study.
Allen SB; Goldenberg NA
Dermatol Surg; 2012 Jun; 38(6):867-70. PubMed ID: 22268727
[TBL] [Abstract][Full Text] [Related]
25. Clinical efficacy of botulinum toxin type A reconstituted and refrigerated 1 week before its application in external canthus dynamic lines.
Lizarralde M; Gutiérrez SH; Venegas A
Dermatol Surg; 2007 Nov; 33(11):1328-33; discussion 1333. PubMed ID: 17958584
[TBL] [Abstract][Full Text] [Related]
26. Botox: shaken, not stirred.
Kazim NA; Black EH
Ophthalmic Plast Reconstr Surg; 2008; 24(1):10-2. PubMed ID: 18209633
[TBL] [Abstract][Full Text] [Related]
27. Questioning the need to use Botox within 4 hours of reconstitution: a study of fresh vs 2-week-old Botox.
Yang GC; Chiu RJ; Gillman GS
Arch Facial Plast Surg; 2008; 10(4):273-9. PubMed ID: 18645097
[TBL] [Abstract][Full Text] [Related]
28. Same-patient prospective comparison of Botox versus Dysport for the treatment of primary axillary hyperhidrosis and review of literature.
Vergilis-Kalner IJ
J Drugs Dermatol; 2011 Sep; 10(9):1013-5. PubMed ID: 22052270
[TBL] [Abstract][Full Text] [Related]
29. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
Wissel J; Entner T
Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
[TBL] [Abstract][Full Text] [Related]
30. Understanding the functional anatomy of the frontalis and glabellar complex for optimal aesthetic botulinum toxin type A therapy.
Lorenc ZP; Smith S; Nestor M; Nelson D; Moradi A
Aesthetic Plast Surg; 2013 Oct; 37(5):975-83. PubMed ID: 23846022
[TBL] [Abstract][Full Text] [Related]
31. Primary and adjunctive uses of botulinum toxin type A in the periorbital region.
Balikian RV; Zimbler MS
Facial Plast Surg Clin North Am; 2005 Nov; 13(4):583-90, vii. PubMed ID: 16253845
[TBL] [Abstract][Full Text] [Related]
32. Botulinum toxin A: its expanding role in dermatology and esthetics.
Said S; Meshkinpour A; Carruthers A; Carruthers J
Am J Clin Dermatol; 2003; 4(9):609-16. PubMed ID: 12926979
[TBL] [Abstract][Full Text] [Related]
33. The use of botulinum toxin type A in cosmetic facial procedures.
Jaspers GW; Pijpe J; Jansma J
Int J Oral Maxillofac Surg; 2011 Feb; 40(2):127-33. PubMed ID: 20965695
[TBL] [Abstract][Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
